High False-Positive Rate of (1,3)-beta-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

Tschopp Jonathan; Brunel Anne-Sophie; Spertini OlivierCroxatto AnthonyLamoth FredericBochud Pierre-Yves

首页> 外文期刊>Clinical infectious diseases >High False-Positive Rate of (1,3)-beta-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

【24h】

High False-Positive Rate of (1,3)-beta-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

机译：High False-Positive Rate of (1,3)-beta-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Immunoglobulins and/or therapeutic antibody preparations are associated with a high rate of false-positive (1,3)-beta-D-glucan (BDG) tests in onto-hematological patients routinely screened for fungal infections. The benefit of BDG monitoring shall be balanced against the risk of false-positive tests leading to unnecessary investigations and costs in this population.

著录项

来源
《Clinical infectious diseases》 |2022年第2期|330-333|共4页
作者
Tschopp Jonathan; Brunel Anne-Sophie; Spertini OlivierCroxatto AnthonyLamoth FredericBochud Pierre-Yves;
展开▼
作者单位

University of Lausanne,CHU Vaudois;

Univ Lausanne;

ADMed Microbiol;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类传染病;
关键词
beta-D-glucan; intravenous immunoglobulines; therapeutic antibodies; false-positive; onto-hematology; INVASIVE FUNGAL-INFECTIONS; BETA-D-GLUCAN; EARLY-DIAGNOSIS; 1; 3-BETA-D-GLUCAN; MALIGNANCIES; ANTIGENEMIA; LEUKEMIA; ASSAY;

High False-Positive Rate of (1,3)-beta-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

摘要

著录项

相关主题

期刊订阅